Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues

1. Torres, I.
2. Ortego, J.
3. Valencia, I.
4. García-Palacios, M.V.
5. Aguilar-Diosdado, M.